Tag: patients

41 PALLETS 3129 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 12.5MG 100 NDC COD E:68462016401 FDA PRODUCT COD E NO :62 O C A 22 HTS NO.300 4.90.9221 ANDA NO.78-251 THE RAPEUTICE USE:-BETA- ADRENOA MNBU0552050 001 CEPTOR ANTAGONIST TELMISAR TAN-HCTZ TAB 80MG/25MG 30UD N DC CODE:68462084213 62 O D A 09 3004.90.92.20 202544 TEL MISARTAN AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENS ION, TO LOWER BLOOD PRESSURE. MNBU0552050 001 TOPIRAMATE ER CAP (Q) 200M G 30 NDC CODE:68462037130 30 04.49.00.20 61 M C B 40 2102 78 COLESEVELAM HCL TAB 625M G 180 NDC CODE:68462043318 F DA PRODUCT CODE NO.: 62 B D A 13 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 203480 THERAPEU MNBU0552050 001 TICE USE: - ANTIHYPERLIPO PR OTEINEMIC. TELMISARTAN-HCTZ TAB 80MG/12.5MG 30UD NDC COD E:68462084113 62 O D A 09 30 04.90.92.20 202544 TELMISART AN AND HYDROCHLOROTHIAZIDE T ABLETS ARE INDICATED FOR THE TREATMENT OF HYPERTENSION, T MNBU0552050 001 O LOWER BLOOD PRESSURE. CA RVEDILOL TAB 12.5MG 500 NDC C ODE:68462016405 FDA PRODUCT C ODE NO :62 O C A 22 HTS NO.3 004.90.9221 ANDA NO.78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST SEVELA MER HCL TAB 800MG 180 NDC COD MNBU0552050 001 E:68462044718 FDA PRODUCT COD E NO.: 63 L D A 04 H. T. S N O.: 3004.90.92.60 ANDA NO.:2 04724 THERAPEUTICE USE:SEVEL AMER HYDROCHLORIDE TABLETS A RE A PHOSPHATE BINDER INDICAT ED FOR THE CONTROL OF SERUM P HOSPHORUS IN PATIENTS WITH CH MNBU0552050 001 RONIC KIDNEY DISEASE ON DIAL YSIS DILTIAZEM HCL ER CAP 1 2HR 90MG 100 NDC CODE:6846208 5101 62 O C B 24 3004.49.00. 10 212317 FOR THE TREATMENT OF HYPERTENSION. TACROLIMU S OINT 0.1% 60GM NDC CODE:684 62053465 FDA PRODUCT CODE NO. MNBU0552050 001 : 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 21039 3 THERAPEUTICE USE: - TACROL IMUS IS A TOPICAL IMMUNOSUPPR ESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEV ERE ATOPIC DERMATITIS (ECZEM A). PIMECROLIMUS CREAM 1% 6 MNBU0552050 001 0GM NDC CODE:68462060965 FDA PRODUCT CODE NO.: 61 S C J 0 4 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTI CE USE: - AS SECOUND-LINE THE RAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTME NT OF MILD TO MODERATE ATOPIC MNBU0552050 001 DERMATITIS IN NONIMMUNOCOMP ROMISED ADULT AND CHILDREN 2 YEARS OF AGE SIROLIMUS TAB 1MG 100 NDC CODE:68462068301 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90. 92.15 ANDA NO.: 208691 THERA PEUTICE USE: TO PREVENT REJEC MNBU0552050 001 TION OF KIDNEY TRANSPLANTS. PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C MNBU0552050 001 ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NONIMMUNOCOMPROMIS ED ADULT AND CHILDREN 2 YEAR S OF AGE COMMERCIAL & CUSTO M INVOICE NO. F22587000467 DT . 19.06.2024 F22587000468 DT. 19.06.2024 F22587000469 DT. MNBU0552050 001 19.06.2024 F22587000470 DT. 1 9.06.2024 F22587000471 DT. 19 .06.2024 S/BILL NO: 4010175 D T:20/06/2024 S/BILL NO: 40101 73 DT:20/06/2024 S/BILL NO: 4 010169 DT:20/06/2024 S/BILL N O: 4010170 DT:20/06/2024 S/BI LL NO: 4010172 DT:20/06/2024 MNBU0552050 001 NET WT. 6362.223 KGS 02 DATA LOGGERS HUMIDITY:65% SET TE MPERATURE : +18 DEGREES TEMPE RATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA

AFTER PATIENTS WINE GLASS STEMLESS WINE GLASS AFTER SCHOOL SNACK STEMLESS WINE GLASS BECAUSE STUDENTS STEMLESS WINE GLASS CABINET HINGES ( OVERLAY MODEL - PACK OF 50 ) CERAMIC PIE WEIGHTS - 1.2LB CERAMIC PIE WEIGHTS - 2.2LB COUNTERFEIT BILL DETECTOR PEN GESU6864632 001 COMMUNION CUP FILLER DAILY TO DO LIST NOTEPAD (COLOURED) DRY ERASE LAPBOARDS WITH GRIDS - 25 PACK DRY ERASE LAPBOARDS WITH LINES - 25 PACK DRY ERASE ANSWER PADDLE-25 DRY ERASE BLANK SHEETS - 11 X 9 (10 PACK) DRY ERASE LAPBOARDS TRIANGULAR ENGINEER SCALE RULER PRINTED GESU6864632 001 WOODEN NOVELTY FRAMES - 5 YEARS OF MARRIAGE FLOURESCENT LIGHT COVERS BLUE 4 PACK GRADUATION INVITATIONS KRAFT RECIPE CARDS PANTRY LABELS (100+ PCS) PHARMACIST PRESCRIPTION GIFT STEMLESS WINE GL ASS PICKY EATER PLATES - SPACE GESU6864632 001 RED AND WHITE CHECKERED TABLECLOTHS QUARTERBACK WRISTBAND SINGLE WINDOW YOUTH 10 PACK QUARTERBACK WRISTBAND SINGLE WINDOW YOUTH 5 P ACK KIDS THANK YOU CARDS WITH ENVELOPES

GABAPENTIN TAB 3236 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HLBU9972857 001 HTS NO.3004.90.9236 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT URSODIOL TAB 250MG 100 NDC CODE 68462047301 FDA PRODUCT CODE NO. 63 N C A 25 HLBU9972857 001 H. T. S NO. 3004.49.00.10 ANDA NO. 90-801 THERAPEUTICE USE - FOR THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS" ROPINIROLE TAB 4MG 100 HLBU9972857 001 NDC CODE 68462025801 FDA PRODUCT CODE NO. -62 J C A 17 H. T. S NO. 3004.90.92.40 ANDA NO. - 90-135 THERAPEUTICE USE -TREATMENT OF HLBU9972857 001 PARKINSONISM ROPINIROLE TAB 5MG 100 NDC CODE 68462025901 FDA PRODUCT CODE NO. 62 J C A 17 H. T. S NO. 3004.90.92.40 ANDA NO. - 90-135 HLBU9972857 001 THERAPEUTICE USE -TREATMENT OF PARKINSONISM TROSPIUM CL TAB 20MG 60 NDC CODE 68462046160 FDA PRODUCT CODE NO. -61 K C A 69 H. T. S NO. HLBU9972857 001 3004.49.00.70 ANDA NO. -91-575 THERAPEUTICE USE - TREATMENT OF VENOUS DISEASES URINARY INCONTINENCE THERAPY OXCARBAZEPINE TAB HLBU9972857 001 150MG 100 NDC CODE 68462013701 FDA PRODUCT CODE NO. -61 M C A 45 HTS NO.3004.90.9236 ANDA NO. -77-802 THERAPEUTICE USE -ANTI CONVULSANT AGENT HLBU9972857 001 METRONIDAZOLE VAG GEL 0.75% 70GM NDC CODE 68462018449 FDA PRODUCT CODE NO. 62 L C J 40 H. T. S NO. 3004.90.92.45 ANDA NO. 215794 HLBU9972857 001 THERAPEUTICE USE METRONIDAZOLE VAGINAL GEL IS INDICATED IN THE TREATMENT OF BACTERIAL VAGINOSIS (FORMERLY REFERRED TO AS HAEMOPHILUS VAGINITIS, GARDNERELLA HLBU9972857 001 VAGINITIS, NONSPECIFIC VAGINITIS, CORYNEBACTERIUM VAGINITIS, OR ANAEROBIC VAGINOSIS). CARVEDILOL TAB 6.25MG 500 NDC CODE 68462016305 FDA PRODUCT CODE NO HLBU9972857 001 62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE

AFTER PATIENTS WINE GLASS STEMLESS WINE GLASS AFTER SCHOOL SNACK STEMLESS WINE GLASS BECAUSE STUDENTS STEMLESS WINE GLASS CABINET HINGES ( OVERLAY MODEL GESU6864632 001 - PACK OF 50 ) CERAMIC PIE WEIGHTS - 1.2LB CERAMIC PIE WEIGHTS - 2.2LB COUNTERFEIT BILL DETECTOR PEN COMMUNION CUP FILLER DAILY TO DO LIST NOTEPAD (COLOURED) DRY ERASE LAPBOARDS WITH GRIDS GESU6864632 001 - 25 PACK DRY ERASE LAPBOARDS WITH LINES - 25 PACK DRY ERASE ANSWER PADDLE-25 DRY ERASE BLANK SHEETS - 11 X 9 (10 PACK) DRY ERASE LAPBOARDS TRIANGULAR ENGINEER SCALE GESU6864632 001 RULER PRINTED WOODEN NOVELTY FRAMES - 5 YEARS OF MARRIAGE FLOURESCENT LIGHT COVERS BLUE 4 PACK GRADUATION INVITATIONS KRAFT RECIPE CARDS PANTRY LABELS (100 PCS) GESU6864632 001 PHARMACIST PRESCRIPTION GIFT STEMLESS WINE GLASS PICKY EATER PLATES - SPACE RED AND WHITE CHECKERED TABLECLOTHS QUARTERBACK WRISTBAND SINGLE WINDOW YOUTH 10 PACK QUARTERBACK WRISTBAND SINGLE GESU6864632 001 WINDOW YOUTH 5 PACK KIDS THANK YOU CARDS WITH ENVELOPES HS CODE 3924102000 8302106060 6912005000 9608200000 GESU6864632 001 4820102020 9610000000 9017204000 4414900000 6307909891 4909004000 4911998000 4821902000 GESU6864632 001 3924901050 9506992000 2ND NOTIFY:DAMCO DISTRIBUTION SERVICES INC 85 RAYO AVE, 90280 SOUTH GATE UNITED STATES EMAI SOUTHGATEDCM MAERSK.COM

DISPOSABLE FACE MASK TIE ON/ MASK EARLOOP PP STIC CUFF,BLUE ISOLATION GOWNS AND WAIST WITH TIE-ON, PATIENTS GOWN, PP CAP WITH TIE

1968 BOXES CONT. GAUZE DRESSINGS AND BANDAGES FOR EMERGENCY TRAUMA ON 20 PALLETS72 BOXES C ONT. SURVIVAL BLANKETS FOR TRAUMA PATIENTS AL L FOR EMERGENCY MEDICAL USE ON 1 PALLET

1968 BOXES CONT. GAUZE DRESSINGS AND BANDAGES FOR EMERGENCY TRAUMA ON 20 PALLETS72 BOXES C ONT. SURVIVAL BLANKETS FOR TRAUMA PATIENTS AL L FOR EMERGENCY MEDICAL USE ON 1 PALLET

TABLE 2 BOXES CONTAIN OT TABLE HS CODE- 94029020 GROSS WEIGHT 320 ( KGS) NET WEIGHT 302 ( KGS) CBM 2 BSIU9647700 001 NEBULIZER MASK NECK COLLARS BLOOD TESTERS PATIENTS WALKERS THERMOMETERS GRIPE WATER SYRINGES SURGICAL AND MEDICAL PRODUCTS HS CODE- 87131010 BSIU9647700 001 PIECE COUNT 125 GROSS WEIGHT 1942.27 ( KGS) NET WEIGHT 1831.9 ( KGS) CBM 15 BSIU9647700 002 NET WEIGHT 11472.3 ( KGS) CBM 23

BOXES CONT. SURVIVAL BLANKETS FOR TRAUMA PATIENTS ON 1 PKG ALL FOR EMERGENCY MEDICAL USE.

Picky Eater Plates After Patients Wine Glass Stemless Wine Glass basketball clipboard dry erase DND Battle Mat Because Students Stemless Wine Glass Bible Verse Cards Cabinet hinges ( Overlay model - Pack of 50 ) TGBU6478179 001 cash envelope small ceramic pie weights - 1.2lb ceramic pie weights - 2.2lb Colored Frame Dry Erase Board (Blank/Lines) Counterfeit Bill Detector Pen 12 pack Carpet Spot Markers (No Numbers) Carpet Spot Markers (With Numbers) Communion Cups - 2000 pcs TGBU6478179 001 Communion Cup Filler Daily to do list notepad (Coloured) DND Battle Mat 9 Pack DND Battle Mat Terrain 4 Pack Dry Erase Lapboards with Grids - 1 Pack Dry Erase Lapboards with Grids - 25 Pack Dry Erase Magnetic Labels Dry Erase Lapboards - 1 Pack TGBU6478179 001 Dry Erase Lapboards with Lines - 25 Pack dry erase multiplication board Dry Erase Answer Paddle Dry Erase Blank Sheets - 11 x 9 (10 Pack) dry erase lapboards triangular engineer scale ruler Printed Faux pampas grass Foam airplanes (2 Pack - 17.5 ) TGBU6478179 001 Flourescent Light Covers Blue 4 Pack Gender Reveal Invitations with Envelopes Ice Cream Cups - 12 oz Ice Cream Cups - 5 oz Ice Cream Cups - 8 oz Fluorescent Light Covers Blue 8 Pack Fluorescent Light Covers White 4 Pack Fluorescent Light Covers White 8 Pack TGBU6478179 001 Lunch Box Notes Magnetic Desktop Foldable Whiteboard magnetic dry erase lap boards - blank (5) Maid of Honor Stemless Wine Glass Mermaid Stemless Wine Glass Metal Plant Labels Waterproof Mr and Mrs Apron 2024 Pharmacist Prescription Gift Stemless Wine Gl TGBU6478179 001 Red and White Checkered Tablecloths Safety First Drink With A Nurse Stemless Wine Quarterback Wristband Single Window Adult 10 Quarterback Wristband Single Window Adult 20 Quarterback Wristband Single Window Youth 10 Quarterback Wristband Single Window Youth 20 Quarterback Wristband Single Window Youth 5 P Sisters Stemless Wine Glass TGBU6478179 001 Lets Get Slothed Stemless Wine Glass Teacher Punch Cards thank you stickers for small business (2 inc Thank You Cards Wedding treadmill belt lubricant 8 oz Wall Collage Kit Blue - 100 PVC dust collection hose - 4 inch x 10 feet

PICKY EATER PLATES AFTER PATIENTS WINE GLASS STEMLESS WINE GLASS BASKETBALL CLIPBOARD DRY ERASE DND BATTLE MAT BECAUSE STUDENTS STEMLESS WINE GLASS BIBLE VERSE CARDS CABINET HINGES ( OVERLAY MODEL - PACK OF 50 ) TGBU6478179 001 CASH ENVELOPE SMALL CERAMIC PIE WEIGHTS - 1.2LB CERAMIC PIE WEIGHTS - 2.2LB COLORED FRAME DRY ERASE BOARD (BLANK/LINES) COUNTERFEIT BILL DETECTOR PEN 12 PACK CARPET SPOT MARKERS (NO NUMBERS) CARPET SPOT MARKERS (WITH NUMBERS) COMMUNION CUPS - 2000 PCS TGBU6478179 001 COMMUNION CUP FILLER DAILY TO DO LIST NOTEPAD (COLOURED) DND BATTLE MAT 9 PACK DND BATTLE MAT TERRAIN 4 PACK DRY ERASE LAPBOARDS WITH GRIDS - 1 PACK DRY ERASE LAPBOARDS WITH GRIDS - 25 PACK DRY ERASE MAGNETIC LABELS DRY ERASE LAPBOARDS - 1 PACK TGBU6478179 001 DRY ERASE LAPBOARDS WITH LINES - 25 PACK DRY ERASE MULTIPLICATION BOARD DRY ERASE ANSWER PADDLE DRY ERASE BLANK SHEETS - 11 X 9 (10 PACK) DRY ERASE LAPBOARDS TRIANGULAR ENGINEER SCALE RULER PRINTED FAUX PAMPAS GRASS FOAM AIRPLANES (2 PACK - 17.5") TGBU6478179 001 FLOURESCENT LIGHT COVERS BLUE 4 PACK GENDER REVEAL INVITATIONS WITH ENVELOPES ICE CREAM CUPS - 12 OZ ICE CREAM CUPS - 5 OZ ICE CREAM CUPS - 8 OZ FLUORESCENT LIGHT COVERS BLUE 8 PACK FLUORESCENT LIGHT COVERS WHITE 4 PACK FLUORESCENT LIGHT COVERS WHITE 8 PACK TGBU6478179 001 LUNCH BOX NOTES MAGNETIC DESKTOP FOLDABLE WHITEBOARD MAGNETIC DRY ERASE LAP BOARDS - BLANK (5) MAID OF HONOR STEMLESS WINE GLASS MERMAID STEMLESS WINE GLASS METAL PLANT LABELS WATERPROOF MR AND MRS APRON 2024 PHARMACIST PRESCRIPTION GIFT STEMLESS WINE GL TGBU6478179 001 ASS RED AND WHITE CHECKERED TABLECLOTHS SAFETY FIRST DRINK WITH A NURSE STEMLESS WINE GLASS QUARTERBACK WRISTBAND SINGLE WINDOW ADULT 10 PACK QUARTERBACK WRISTBAND SINGLE WINDOW ADULT 20 PACK TGBU6478179 001 QUARTERBACK WRISTBAND SINGLE WINDOW YOUTH 10 PACK QUARTERBACK WRISTBAND SINGLE WINDOW YOUTH 20 PACK QUARTERBACK WRISTBAND SINGLE WINDOW YOUTH 5 P ACK SISTERS STEMLESS WINE GLASS LETS GET SLOTHED STEMLESS WINE GLASS TGBU6478179 001 TEACHER PUNCH CARDS THANK YOU STICKERS FOR SMALL BUSINESS (2" INC H) THANK YOU CARDS WEDDING TREADMILL BELT LUBRICANT 8 OZ WALL COLLAGE KIT BLUE - 100 PVC DUST COLLECTION HOSE - 4 INCH X 10 FEET

40 PALLETS 2197 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 25MG 500 NDC CODE: 68462016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004. 90.9221 ANDA NO.78-251 THERA PEUTICE USE:-BETA- ADRENOACE MNBU0602763 001 PTOR ANTAGONIST NICARDIPIN E HCL CAP 30MG 90 NDC CODE:68 462012190 FDA PRODUCT CODE NO .: 62 O C E 48 H. T. S NO.: 3004.90.9220 ANDA NO.: 21635 7 THERAPEUTICE USE: :#CARDIO VASCULAR AGENT (CALCIUM CHANN EL BLOCKER) EZETIMIBE-SIMV MNBU0602763 001 A TAB 10/20MG 30 NDC CODE:684 62032230 FDA PRODUCT CODE NO. : 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: :#LIPID LOWERING AGENT GABAPENTIN T AB 600MG 500 NDC CODE:6846201 2605 FDA PRODUCT CODE:NO : 6 MNBU0602763 001 1 N C A 69 HTS NO.3004.90.923 6 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT PR OPAFENONE HCL ER CAP 225MG 60 NDC CODE:68462040860 FDA PRO DUCT CODE NO.: 63 E C F 28 H . T. S NO.: 3004.49.00.10 AN DA NO.:205268 THERAPEUTICE US MNBU0602763 001 E:AN ANTIARRHYTHMIC AGENT. I T IS USED TO TREAT IRREGULAR HEART RHYTHM AND CAN SLOW RA PID HEARTBEATS EZETIMIBE-S IMVA TAB 10/20MG 90 NDC CODE: 68462032290 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO. : 3004.49.00.10 ANDA NO.: 20 MNBU0602763 001 8699 THERAPEUTICE USE: :#LIP ID LOWERING AGENT RUFINAMID E TAB 400MG 120 NDC CODE:6846 2071408 61 M C A 99 3004.90. 92.30 205075 TO USED WITH OT HER MEDICATIONS TO PREVENT OR CONTROL SEIZURES (EPILEPSY) ASSOCIATED WITH LENNOX-GAST MNBU0602763 001 AUT SYNDROME (LGS BISOPROL OL-HCTZ TAB 10/6.25MG 30 NDC CODE:68462088030 FDA PRODUCT CODE NO :62 O D A 18 HTS NO. 3004.49.0010 ANDA NO.215995 THERAPEUTICE USE:-BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED IN MNBU0602763 001 THE MANAGEMENT OF HYPERTENS ION. FENOFIBRATE CAP 67MG 1 00 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 A NDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIV E THERAPY TO DIET FOR THE RE MNBU0602763 001 DUCTION OF LDL-C, TOTAL-C, TR IGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPER CHOLESTEROLEMIA OR MIXED DYSL IPIDEMIA CARVEDILOL TAB 25M G 500 NDC CODE:68462016505 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA MNBU0602763 001 NO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST TACROLIMUS OINT 0.1% 100 GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTIC E USE: - TACROLIMUS IS A TOPI MNBU0602763 001 CAL IMMUNOSUPPRESSIVE OINTME NT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DE RMATITIS (ECZEMA). TACROLI MUS OINT 0.1% 30GM NDC CODE:6 8462053435 FDA PRODUCT CODE N O.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210 MNBU0602763 001 393 THERAPEUTICE USE: - TACR OLIMUS IS A TOPICAL IMMUNOSUP PRESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE-TO-S EVERE ATOPIC DERMATITIS (ECZ EMA). PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 F DA PRODUCT CODE NO.: 61 S C J MNBU0602763 001 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 211769 THERAPEU TICE USE: - AS SECOUND-LINE T HERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERT MENT OF MILD TO MODERATE ATOP IC DERMATITIS IN NONIMMUNOCO MPROMISED ADULT AND CHILDREN MNBU0602763 001 2 YEARS OF AGE TACROLIMUS OINTMENT 0.03% 100GM NDC CODE :68462088194 FDA PRODUCT CODE NO.:64 T C J 08 H. T. S NO. : 3004.49.0050 ANDA NO.:2103 93 THERAPEUTICE USE: TOPICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & CUSTOM INVOICE NO MNBU0602763 001 . F22487001926 DT. 22.01.2024 F22487001922 DT. 20.01.2024 F22487001921 DT. 20.01.2024 F22487001920 DT. 20.01.2024 F 22487001919 DT. 20.01.2024 F2 2487001917 DT. 20.01.2024 S/B ILL NO: 4001056 DT: 22/01/2024 S/BILL NO: 4001055 DT: 22/01 MNBU0602763 001 /2024 S/BILL NO: 4001053 DT: 22/01/2024 S/BILL NO: 4001054 DT: 22/01/2024 S/BILL NO: 40 01052 DT: 22/01/2024 S/BILL N O: 4001051 DT: 22/01/2024 NET WT. 5823.454 KGS 02 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +20 DEGREES TEMPERAT MNBU0602763 001 URE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH-07430 USA

DONATIONS TO THE GOVERNMENT HOSPITALS - HOSPITAL BEDS / STRETCHERS AND MEDICAL EQUIPMENT RELATED ITEMS FOR PATIENTS ADMITTED TO THE GOVERNMENT HOSPITALS IN SRI LANKA. THESE GOODS ARE GIVEN FREE OF CHARGE BY HOSPITAL SERVICES SUPPORT FOUNDATION CALIFORNIA ***EMAIL:HOSPITALSERVICES.LK@GMAIL.COM EMAIL: PRABHATH@HOSPITALSSF.ORG **EMAIL1:MOH.COVID.COORDINATOR@GMAIL.COM EMAIL2:POSTMASTER@HEALTH.GOV.LK

37 PALLETS 2335 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - MNBU0437740 001 TREATMENT OR PREVENTION OF HYPOKALEMIA RUFINAMIDE TAB 400MG 120 NDC CODE:6846207140 8 61 M C A 99 3004.90.92.30 205075 TO USED WITH OTHER M EDICATIONS TO PREVENT OR CONT ROL SEIZURES (EPILEPSY) ASSO CIATED WITH LENNOX-GASTAUT S MNBU0437740 001 YNDROME (LGS SAXAGLIPTIN TA B 5MG 30 NDC CODE:68462072730 FDA PRODUCT CODE NO.:61 P C A 99 H. T. S NO.: 3004.90.9 220 ANDA NO.:205994 THERAPEU TICE USE: :#ANTI-DIABETIC AGE NT INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA MNBU0437740 001 PRODUCT CODE: 62 GCE42 H. T . S NO.:3004.90.92.40 ANDA N O.203501 THERAPEUTIC USE: IN DOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT ST IFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITI S. IT IS ALSO USED TO RELIEVE MNBU0437740 001 PAIN FROM VARIOUS OTHER CON DITIONS. THIS MEDICATION IS K NOWN AS A NONSTEROIDAL ANTI- INFLAMMATORY DRUG (NSAID). .. . THIS EFFECT HELPS TO DECRE ASE SWELLING AND PAIN. FEN OFIBRATE CAP 200MG 100 NDC CO DE:68462058201 FDA PRODUCT CO MNBU0437740 001 DE NO.: 61 JCE 09 H. T. S NO .: 3004.90.92.20 ANDA NO.: 2 05566 THERAPEUTICE USE: - IN DICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDE S AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTERO MNBU0437740 001 LEMIA OR MIXED DYSLIPIDEMIA FENOFIBRATE CAP 134MG 100 N DC CODE:68462058101 FDA PRODU CT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA N O.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIVE TH ERAPY TO DIET FOR THE REDUCTI MNBU0437740 001 ON OF LDL-C, TOTAL-C, TRIGLYC ERIDES AND APO B IN DULT PAT IENTS WITH PRMARY HYPERCHOLE STEROLEMIA OR MIXED DYSLIPIDE MIA NAPROXEN SOD TAB 275MG 100 NDC CODE:68462017801 FDA PRODUCT CODE NO.:-62 G C A 5 0 H. T. S NO.: 3004.90.92.40 MNBU0437740 001 ANDA NO.:-78-314 THERAPEUTI CE USE:-ANTI -INFLAMMATORY, A NALGESIC TACROLIMUS OINT 0. 1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49. 00.50 ANDA NO.: 210393 THERA PEUTICE USE: - TACROLIMUS IS MNBU0437740 001 A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATME NT OF MODERATE-TO-SEVERE ATO PIC DERMATITIS (ECZEMA). T ACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO MNBU0437740 001 .: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMM UNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERAT E-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS CAP 0.5MG 100 NDC CODE:6846206850 1 FDA PRODUCT CODE NO.: 64 T MNBU0437740 001 C E 08 H. T. S NO.:3004.90. 92.15 ANDA NO.: 206662 THERA PEUTICE USE: :#TO PREVENT REJ ECTION OF A KIDNEY,TO PREVENT REJECTION OF A KIDNEY,LIVER TRANSPLANT TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HTS NO: 3004.90.92.15 FDA CO MNBU0437740 001 DE : 64 T C E 08 ANDA NO.2066 62 THERAPEUTIC USE : TO PREV ENT REJECTION OF A KIDNEY,HEA RT, OR LIVER TRANSPLANT CO MMERCIAL & CUSTOM INVOICE NO. F22487001748 DT. 30.12.2023 F22487001749 DT. 30.12.2023 S /BILL NO: 4020294 DT:30/12/202 MNBU0437740 001 3 S/BILL NO: 4020292 DT:30/12 /2023 NET WT. 3110.165 KGS 02 DATA LOGGERS SET TEMPE RATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTI CALS INC 750, CORPORATE DRIVE , NEW JERSEY MAHWAH - 07430 USA

24 PALLETS 2163 CARTONS PH ARMACEUTICALS AS UNDER EZET IMIBE TAB 10MG 500 NDC CODE:6 8462022605 FDA PRODUCT CODE N O.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #07 8560 THERAPEUTICE USE: LIPID MNBU0585590 001 LOWERING AGENT EZETIMIBE T AB 10MG 90 NDC CODE:684620226 90 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: #078560 TH ERAPEUTICE USE: LIPID LOWERIN G AGENT FENOFIBRATE CAP 134 MG 100 NDC CODE:68462058101 MNBU0585590 001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUN CTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C , TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY H MNBU0585590 001 YPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVEDILOL TAB 25MG 500 NDC CODE:6846201650 5 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90 .92.20 ANDA NO.:- 78-251 THE RAPEUTICE USE:-BETA- ADRENOA CEPTOR ANTAGONIST GABAPENT MNBU0585590 001 IN TAB 600MG 500 NDC CODE:684 62012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3 004.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVU LSANT AGENT TACROLIMUS OIN TMENT 0.03% 60GM NDC CODE:684 62088165 FDA PRODUCT CODE NO MNBU0585590 001 .:64 T C J 08 H. T. S NO.: 3 004.49.0050 ANDA NO.:210393 THERAPEUTICE USE: TOPICAL IM MUNOSUPPRESSIVE AGENT TACR OLIMUS OINTMENT 0.03% 100GM N DC CODE:68462088194 FDA PRODU CT CODE NO.:64 T C J 08 H. T . S NO.: 3004.49.0050 ANDA N MNBU0585590 001 O.:210393 THERAPEUTICE USE: TOPICAL IMMUNOSUPPRESSIVE AG ENT COMMERCIAL & CUSTOM INV OICE NO. F22487001409 DT. 09. 11.2023 F22487001411 DT. 09.1 1.2023 F22487001414 DT. 09.11 .2023 S/BILL NO: 4017371 DT: 09.11.2023 S/BILL NO: 4017374 MNBU0585590 001 DT: 09.11.2023 S/BILL NO: 40 17376 DT: 09.11.2023 NET WT. 3784.776 KGS 02 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO MNBU0585590 001 RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA

47 PALLETS 2422 CARTONS PHARMACEUTICALS AS UNDER GABAPENTIN TAB 800MG 500 ND C CODE:68462012705 FDA PRODU CT CODE NO : 61 N C A 69 H . T. S NO.: 3004.90.92.30 ANDA NO.:-77-662 THERAPEUTIC MNBU0261348 001 E USE:-ANTICONVULSANT AGEN T GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.3 0 ANDA NO.:-77-662 THERAPE UTICE USE:-ANTICONVULSANT AGENT URSODIOL TAB 250MG 1 MNBU0261348 001 00 NDC CODE:68462047301 FD A PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49.0 0.10 ANDA NO.: 90-801 THER APEUTICE USE: - FOR THE TREA TMENT OF PATIENTS WITH PRIMA RY BILIARY CIRRHOSIS" U RSODIOL TAB 250MG 100 NDC CO MNBU0261348 001 DE:68462047301 FDA PRODUCT C ODE NO.: 63 N C A 25 H. T. S NO.: 3004.49.00.10 ANDA NO.: 90-801 THERAPEUTICE US E: - FOR THE TREATMENT OF PATIENTS WITH PRIMARY BILIAR Y CIRRHOSIS" RIZATRIPTAN BENZ TAB 5MG 18UD NDC CODE:6 MNBU0261348 001 8462046599 FDA PRODUCT CODE NO.: 60 L C A 87 H. T. S N O.: 3004.90.92.28 ANDA NO. :201967 THERAPEUTICE USE: - ACUTE TREATMENT OF MIGRAIN E TOPIRAMATE TAB 50MG 6 0 NDC CODE:68462015360 FDA PRODUCT CODE NO.:-61 M C A MNBU0261348 001 40 H. T. S NO.: 3004.49.00 .20 ANDA NO.:- 77-627 THER APEUTICE USE:-ANTICONVULSANT OMEPRAZOLE DR CAP 20MG 1 000 NDC CODE:68462039610 F DA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUT MNBU0261348 001 ICE USE: - -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX DISEASE NORETH ACE/EE TAB 0.5MG/2.5MCG 84 NDC CODE:68 462065629 FDA PRODUCT CODE N O.: 65 J D A 25 H. T. S NO .: 3006.60.00.00 ANDA NO.: 203038 THERAPEUTICE USE: - MNBU0261348 001 TREATMENT OF MODERATE TO S EVERE VASOMOTOR SYMPTOMS D UE TO MENOPAUSE; OSTEOPOROSI S PREVENTION NORETH ACE /EE TAB 0.5MG/2.5MCG 84 NDC CODE:68462065629 FDA PRODUCT CODE NO.: 65 J D A 25 H. T. S NO.: 3006.60.00.00 AN MNBU0261348 001 DA NO.: 203038 THERAPEUTICE USE: - TREATMENT OF MODERATE TO SEVERE VASOMOTOR SYMPT OMS DUE TO MENOPAUSE; OSTE OPOROSIS PREVENTION COM MERCIAL & CUSTOM INVOICE NO. F22452003509 DT. 22.10.2023 F22452003510 DT. 22.10.2023 MNBU0261348 001 F22452003511 DT. 22.10.2023 F22452003512 DT. 22.10.2023 F22452003513 DT. 22.10.2023 F22452003515 DT. 22.10.2023 F22452003524 DT. 23.10.2023 S/BILL NO: 4841128 DT 23-OC T-2023 S/BILL NO: 4838257 DT 23-OCT-2023 S/BILL NO: 483826 MNBU0261348 001 4 DT 23-OCT-2023 S/BILL NO: 4 838262 DT 23-OCT-2023 S/BILL NO: 4842051 DT 23-OCT-2023 S/ BILL NO: 4838258 DT 23-OCT-202 3 S/BILL NO: 4841129 DT 23-OC T-2023 NET WT. 9,639.59 8 KGS 02 DATA LOGGERS S ET TEMPERATURE : +18 DEGREES MNBU0261348 001 NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA

29 PALLETS 2278 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA N O.: 202868 THERAPEUTICE USE: MNBU0146046 001 - TREATMENT OR PREVENTION OF HYPOKALEMIA FENOFIBRATE CA P 67MG 100 NDC CODE:684620580 01 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90. 92.20 ANDA NO.: 205566 THERA PEUTICE USE: - INDICATED AS A DJUNCTIVE THERAPY TO DIET FOR MNBU0146046 001 THE REDUCTION OF LDL-C, TOT AL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMAR Y HYPERCHOLESTEROLEMIA OR MI XED DYSLIPIDEMIA FENOFIBRAT E CAP 134MG 100 NDC CODE:6846 2058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 300 MNBU0146046 001 4.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIE T FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROLEMIA O R MIXED DYSLIPIDEMIA TACRO MNBU0146046 001 LIMUS CAP 1MG 100 NDC CODE:68 462068601 HTS NO: 3004.90.92. 15 FDA CODE : 64 T C E 08 AN DA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSP LANT TACROLIMUS OINT 0.1% 3 0GM NDC CODE:68462053435 FDA MNBU0146046 001 PRODUCT CODE NO.: 64 T C J 0 8 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTI CE USE: - TACROLIMUS IS A TOP ICAL IMMUNOSUPPRESSIVE OINTM ENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC D ERMATITIS (ECZEMA). GABAPE MNBU0146046 001 NTIN TAB 600MG 500 NDC CODE:6 8462012605 FDA PRODUCT CODE N O: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-6 62 THERAPEUTICE USE:-ANTICON VULSANT AGENT COMMERCIAL & CUSTOM INVOICE NO. F22487001 279 DT. 19.10.2023 F224870012 MNBU0146046 001 81 DT. 19.10.2023 F2248700128 6 DT. 19.10.2023 S/BILL NO: 4 016169 DT: 19.10.2023 S/BILL NO: 4016171 DT: 19.10.2023 S/ BILL NO: 4016172 DT: 19.10.202 3 NET WT. 3467.777 KGS 02 D ATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TE MNBU0146046 001 MPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA

27 PALLETS 1356 CARTONS PH ARMACEUTICALS AS UNDER TACR OLIMUS CAP 1MG 100 NDC CODE:6 8462068601 HTS NO: 3004.90.92 .15 FDA CODE : 64 T C E 08 A NDA NO.206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A SUDU8246664 001 KIDNEY,HEART, OR LIVER TRANS PLANT TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FD A PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.5 0 ANDA NO.: 210393 THERAPEUT ICE USE: - TACROLIMUS IS A TO PICAL IMMUNOSUPPRESSIVE OINT SUDU8246664 001 MENT USED FOR THE TREATMENT O F MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). CLIND AMYCIN HCL CAP 75MG 100 NDC C ODE:68462014201 PRAVASTATIN SOD TAB 80MG 90 NDC CODE:684 62019890 FDA PRODUCT CODE NO .:-61 J C A 13 H. T. S NO.: SUDU8246664 001 3004.90.92.20 ANDA NO.:-77-98 7 THERAPEUTICE USE:-HYPOLIPD AEMIC FENOFIBRATE CAP 67MG 100 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTI SUDU8246664 001 VE THERAPY TO DIET FOR THE R EDUCTION OF LDL-C, TOTAL-C, T RIGLYCERIDES AND APO B IN DUL T PATIENTS WITH PRMARY HYPE RCHOLESTEROLEMIA OR MIXED DYS LIPIDEMIA CLINDAMYCIN HCL C AP 300MG 100 NDC CODE:6846201 4401 FDA PRODUCT CODE NO.:56 SUDU8246664 001 J C E 20 H. T. S NO.: 2941. 90.5000 ANDA NO.:216957 THER APEUTICE USE: :#TREATMENT OF NUMEROUS INFECTIONS, INCLUDIN G BUT NOT LIMITED TO SEPTIC EMIA,INTRAABDOMINAL INFECTION S, LOWER RESPIRATORY INFECTI ONS, GYNECOLOGICAL INFECTIONS SUDU8246664 001 , BONE AND JOINT INFECTIONS, AND SKIN AND SKIN STRUCTURE INFECTIONS COMMERCIAL & CUS TOM INVOICE NO. F22487001233 DT. 10.10.2023 F22487001234 D T. 10.10.2023 F22487001235 DT . 10.10.2023 S/BILL NO: 40156 89 DT: 11.10.2023 S/BILL NO: SUDU8246664 001 4015692 DT: 11.10.2023 S/BILL NO: 4015690 DT: 11.10.2023 N ET WT. 2560.638 KGS 02 DATA L OGGERS SET TEMPERATURE : +1 8 DEGREES NOTIFY PARTY:2 G LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA

38 PALLETS 2370 CARTONS PH ARMACEUTICALS AS UNDER POTA SSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO .:202868 THERAPEUTICE USE: - MNBU0523406 001 TREATMENT OR PREVENTION OF HYPOKALEMIA INDOMETHACIN ER CAP 75MG 100 NDC CODE:684620 32501 FDA PRODUCT CODE NO.: 62GCE42 H. T. S NO.: 3004.90 .92.40 ANDA NO.: 203501 THER APEUTICE USE: :#INDOMETHACIN IS USED TO RELIEVE PAIN, SWE MNBU0523406 001 LLING,AND JOINT STIFFNESS CAU SED BY ARTHRITIS, GOUT, BURS ITIS,AND TENDONITIS.AND TEND ONITIS.IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS AS DEC REASE SWELLING ANDTHIS EFFECT HELPS TOANTI-INFLAMMATORY D RUGA NONSTEROIDALTHIS MEDICAT MNBU0523406 001 ION IS KNOWNCONDITIONS. IN DOMETHACIN ER CAP 75MG 60 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO. :3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE: INDOMETHAC IN IS USED TO RELIEVE PAIN, S WELLING, AND JOINT STIFFNESS MNBU0523406 001 CAUSED BY ARTHRITIS, GOUT, BU RSITIS, AND TENDONITIS. IT I S ALSO USED TO RELIEVE PAIN F ROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMA TORY DRUG (NSAID). ... THIS EFFECT HELPS TO DECREASE SWEL MNBU0523406 001 LING AND PAIN. CARVEDILOL TAB 25MG 500 NDC CODE:6846201 6505 FDA PRODUCT CODE NO : 6 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST INDOM ETHACIN ER CAP 75MG 60 NDC CO MNBU0523406 001 DE:68462032560 FDA PRODUCT CO DE: 62 GCE42 H. T. S NO.:30 04.90.92.40 ANDA NO.203501 T HERAPEUTIC USE: INDOMETHACIN IS USED TO RELIEVE PAIN, SWEL LING, AND JOINT STIFFNESS CAU SED BY ARTHRITIS, GOUT, BURSI TIS, AND TENDONITIS. IT IS A MNBU0523406 001 LSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. T HIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATOR Y DRUG (NSAID). ... THIS EFF ECT HELPS TO DECREASE SWELLIN G AND PAIN. ASPIRIN-ER DIP YRIDAMOLE CAP 25/200MG 60 NDC MNBU0523406 001 CODE:68462040560 FDA PRODUCT CODE NO.: 60 L D F 05 H. T. S NO.: 3004.90.9220 ANDA NO .:210318 TACROLIMUS CAP 1MG 100 NDC CODE:68462068601 HT S NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE : TO PREVENT MNBU0523406 001 REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT TACRO LIMUS OINT 0.1% 100GM NDC COD E:68462053494 FDA PRODUCT COD E NO.: 64 T C J 08 H. T. S N O.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - T ACROLIMUS IS A TOPICAL IMMUNO MNBU0523406 001 SUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-T O-SEVERE ATOPIC DERMATITIS ( ECZEMA). SEVELAMER HCL TAB 800MG 180 NDC CODE:6846204471 8 FDA PRODUCT CODE NO.: 63 L D A 04 H. T. S NO.: 3004.90 .92.60 ANDA NO.:204724 THERA MNBU0523406 001 PEUTICE USE:SEVELAMER HYDROC HLORIDE TABLETS ARE A PHOSPHA TE BINDER INDICATED FOR THE C ONTROL OF SERUM PHOSPHORUS IN PATIENTS WITH CHRONIC KIDNE Y DISEASE ON DIALYSIS PROP AFENONE HCL ER CAP 225MG 60 N DC CODE:68462040860 FDA PRODU MNBU0523406 001 CT CODE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.:205268 THERAPEUTICE USE: AN ANTIARRHYTHMIC AGENT. IT IS USED TO TREAT IRREGULAR HE ART RHYTHM AND CAN SLOW RAPI D HEARTBEATS COMMERCIAL & CUSTOM INVOICE NO. F224870011 MNBU0523406 001 00 DT. 22.09.2023 F2248700110 1 DT. 22.09.2023 F22487001102 DT. 22.09.2023 F22487001103 DT. 22.09.2023 F22487001104 D T. 22.09.2023 F22487001105 DT . 22.09.2023 S/BILL NO: 40145 60 DT: 23/09/2023 S/BILL NO: 4014554 DT: 23/09/2023 S/BILL MNBU0523406 001 NO: 4014553 DT: 23/09/2023 S /BILL NO: 4014549 DT: 23/09/20 23 S/BILL NO: 4014551 DT: 23/ 09/2023 S/BILL NO: 4014550 DT : 23/09/2023 NET WT. 4287.102 KGS 03 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC MNBU0523406 001 EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA NOTIFY PARTY:3 GLEN MARK SPECIALTY S.A. SWITZERLA ND (GSSA) PLACE DU PORT 2 NE UCHATEL - 2000 SWITZERLAND

16 PALLETS 1339 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 600MG 100 NDC C ODE:68462013901 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN MNBU0471766 001 TI CONVULSANT AGENT OXCARB AZEPINE TAB 600MG 100 NDC COD E:68462013901 FDA PRODUCT COD E NO.:-61 M C A 45 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT URSODIOL TAB 250MG 100 NDC CODE:68462 MNBU0471766 001 047301 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 30 04.49.00.10 ANDA NO.: 90-801 "'THERAPEUTICE USE: - FOR TH E TREATMENT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS" COMMERCIAL & CUSTOM INVOICE N O. F22452002711 DT. 05.09.202 MNBU0471766 001 3 F22452002717 DT. 06.09.2023 F22452002718 DT. 06.09.2023 S/BILL NO: 3795123 DT 08-SEP- 2023 S/BILL NO: 3795122 DT 08 -SEP-2023 S/BILL NO: 3795172 DT 08-SEP-2023 NET WT. 3850.2 31 KGS 04 DATA LOGGERS SET TEMPERATURE : +18 DEGREES MNBU0471766 001 NOTIFY PARTY:2 GLENMARK PHARM ACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

47 PALLETS 4103 CARTONS PH ARMACEUTICALS AS UNDER CALC IPOTRIENE CREAM 0.005% 60GM N DC CODE:68462050165 FDA PRODU CT CODE NO.: 62 N C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 205772 THERAPEUTICE USE SUDU8172113 001 : - TREATMENT OF PLAQUE PSOR IASIS IN ADULTS ONDANSETRON TAB 4MG 30 NDC CODE:68462010 530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004. 90.92.40 ANDA NO.:- 77-535 T HERAPEUTICE USE:-ANTI -EMETIC OMEPRAZOLE DR CAP 40MG 30 SUDU8172113 001 NDC CODE:68462039730 FDA PRO DUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO .: 91672 THERAPEUTICE USE: - -TREATMENT OF TREAT GASTROES OPHAGEAL REFLUX DISEASE UR SODIOL TAB 500MG 100 NDC CODE :68462047401 FDA PRODUCT CODE SUDU8172113 001 NO.: 63 N C A 25 H. T. S NO .: 3004.49.00.10 ANDA NO.: 9 0-801 THERAPEUTICE USE: - FOR THE TREATMENT OF PATIENTS W ITH PRIMARY BILIARY CIRRHOSIS " OXCARBAZEPINE TAB 600MG 1 00 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 SUDU8172113 001 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039730 FDA PROD UCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO. : 91672 THERAPEUTICE USE: - SUDU8172113 001 -TREATMENT OF TREAT GASTROESO PHAGEAL REFLUX DISEASE COM MERCIAL & CUSTOM INVOICE NO. F22452002745 DT. 08.09.2023 F 22452002719 DT. 06.09.2023 F2 2452002727 DT. 07.09.2023 F22 452002728 DT. 07.09.2023 F224 52002744 DT. 08.09.2023 S/BIL SUDU8172113 001 L NO: 3807185 DT 08-SEP-2023 S/BILL NO: 3807251 DT 08-SEP-2 023 S/BILL NO: 3807193 DT 08- SEP-2023 S/BILL NO: 3807183 D T 08-SEP-2023 S/BILL NO: 3807 208 DT 08-SEP-2023 NET WT: 8, 972.117 KGS 08 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE SUDU8172113 001 : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT SUDU8172113 001 2 NEUCHATEL - 2000 SWITZERL AND

31 PALLETS 2634 CARTONS PHARMACEUTICALS AS UNDER PR OPAFENONE HCL ER CAP 225MG 60 NDC CODE:68462040860 FDA PRO DUCT CODE NO.: 63 E C F 28 H . T. S NO.: 3004.49.00.10 AN DA NO.:205268 THERAPEUTICE US MNBU0520665 001 E:AN ANTIARRHYTHMIC AGENT. I T IS USED TO TREAT IRREGULAR HEART RHYTHM AND CAN SLOW RA PID HEARTBEATS FENOFIBRATE CAP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 205566 T MNBU0520665 001 HERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND A PO B IN DULT PATIENTS WITH P RMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVED ILOL TAB 12.5MG 500 NDC CODE: MNBU0520665 001 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST VORICONAZOLE TAB 200MG 30 N DC CODE:68462057330 FDA PRODU CT CODE NO.:61 W C A 59 H. T MNBU0520665 001 . S NO.: 3004.90.92.10 ANDA NO.:203503 THERAPEUTICE USE: -USED TO TREAT FUNGAL INFECT IONS PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FD A PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 211769 THERAPEUT MNBU0520665 001 ICE USE: - AS SECOUND-LINE TH ERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTM ENT OF MILD TO MODERATE ATOPI C DERMATITIS IN NON- IMMUNO COMPROMISED ADULT AND CHILDRE N 2 YEARS OF AGE EZETIMIBE TAB 10MG 500 NDC CODE:684620 MNBU0520665 001 22605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOWE RING AGENT 02 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES NET WT:5648.991KGS COM MERCIAL & CUSTOM INVOICE NO. MNBU0520665 001 F22487000953 DT. 29.08.2023 F 22487000955 DT. 30.08.2023 F2 2487000956 DT. 30.08.2023 F22 487000958 DT. 30.08.2023 S/BI LL NO:4013197 DT:30.08.2023 S /BILL NO:4013196 DT:30.08.2023 S/BILL NO:4013193 DT:30.08.2 023 S/BILL NO:4013199 DT:30.0 MNBU0520665 001 8.2023 NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA

33 PALLETS 2431 CARTONS PH ARMACEUTICALS AS UNDER RANO LAZINE ER TAB 1000MG 60 NDC C ODE:68462032060 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT MNBU0603097 001 IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA NAPROXEN MNBU0603097 001 SOD TAB 550MG 100 NDC CODE:68 462017901 FDA PRODUCT CODE N O.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-3 14 THERAPEUTICE USE:-ANTI -I NFLAMMATORY, ANALGESIC FENO FIBRATE CAP 134MG 100 NDC COD E:68462058101 FDA PRODUCT COD MNBU0603097 001 E NO.: 61 JCE 09 H. T. S NO. : 3004.90.92.20 ANDA NO.: 20 5566 THERAPEUTICE USE: - IND ICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROL MNBU0603097 001 EMIA OR MIXED DYSLIPIDEMIA CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST TACROLIMUS CAP 5MG 100 MNBU0603097 001 NDC CODE:68462068701 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THER APEUTICE USE: TO PREVENT REJE CTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT PIMECROLI MUS CREAM 1% 100GM NDC CODE:6 8462060994 FDA PRODUCT CODE N MNBU0603097 001 O.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211 769 THERAPEUTICE USE: - AS S ECOUND-LINE THERAPY FOR THE S HORT-TERM AND NON-CONTINUOS C HRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMPROMISED ADULT MNBU0603097 001 AND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C MNBU0603097 001 ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NON- IMMUNOCOMPR OMISED ADULT AND CHILDREN 2 YEARS OF AGE POTASSIUM CL E R CAP 10MEQ 500 NDC CODE:6846 2035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3 MNBU0603097 001 004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATME NT OR PREVENTION OF HYPOKALEM IA CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE MNBU0603097 001 USE:-BETA- ADRENOACEPTOR AN TAGONIST COMMERCIAL & CUSTO M INVOICE NO. F22487000922 DT . 22.08.2023 F22487000924 DT. 22.08.2023 F22487000925 DT. 23.08.2023 F22487000928 DT. 2 3.08.2023 F22487000929 DT. 23 .08.2023 S/BILL NO: 4012795 D MNBU0603097 001 T: 23.08.2023 S/BILL NO: 4012 793 DT: 23.08.2023 S/BILL NO: 4012792 DT: 23.08.2023 S/BIL L NO: 4012797 DT: 23.08.2023 S/BILL NO: 4012798 DT: 23.08.2 023 NET WT. 6847.701 KGS 0 2 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES MNBU0603097 001 TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA

THERMOPLASTIC MATERIAL USED MOLDED FOR THE PRODUCTION OF EXTERNAL ORTHOSES AND PROSTHETIC CHECK SOCKETS MEDICAL DEVICE FOR AMPUTEES. MEDICAL DEVICES USED FOR THE IMMOBILIZATION OF CANCER PATIENTS DURING RADIATION TREATMENT. FDA REGISTRATION OWNER OPERATOR 9015000 HS CODE 90211090 FANU1349246 001 90229080

PHARMACEUTICALS PHARMACEUTICALS AS UNDER ONDANSETRON ODT 4MG 30UD NDC CODE 68462015713 FDA PRODUCT CODE NO, -61 T C A 26 H. T. S NO. HLBU9470709 001 3004.49.00.20 ANDA NO. 077627 THERAPEUTICE USE ANTICONVULSANT URSODIOL TAB 250MG 100 NDC CODE 68462047301 FDA PRODUCT CODE NO. 63 N C A 25 HLBU9470709 001 H. T. S NO. 3004.49.00.10 ANDA NO. 90-801 THERAPEUTICE USE - FOR THE TREATMENT OF PATIENTS WITH PRIMARY BILIARY CIRRHOSIS" TOPIRAMATE TAB 50MG 500 HLBU9470709 001 NDC CODE 68462015305 FDA PRODUCT CODE NO. 61 M C A 40 H. T. S NO. 3004.49.00.20 ANDA NO. 077627 THERAPEUTICE USE ANTICONVULSANT HLBU9470709 001 00 DATA LOGGERS HUMIDITY 65% COMMERCIAL & CUSTOM INVOICE NO. F22452002081 DT. 30.07.2023 F22452002088 DT. 31.07.2023 F22452002089 DT. 31.07.2023 9 PALLETS HLBU9470709 001 992 CARTONS HLBU9470709 002 3004.90.92.40 ANDA NO. -78-152 THERAPEUTICE USE -ANTI -EMETIC GABAPENTIN TAB 600MG 500 NDC CODE 68462012605 FDA PRODUCT CODE NO 61 N C A 69 HLBU9470709 002 H. T. S NO. 3004.90.92.30 ANDA NO. -77-662 THERAPEUTICE USE -ANTICONVULSANT AGENT PRAMIPEXOLE TAB 0.25MG 90 NDC CODE 68462033190 HLBU9470709 002 FDA PRODUCT CODE NO. 62 J C A 15 H. T. S NO. 3004.90.92.40 ANDA NO. 90-781 THERAPEUTICE USE USED IN PARKINSONS DISEASE 02 DATA LOGGERS HLBU9470709 002 HUMIDITY 65% COMMERCIAL & CUSTOM INVOICE NO. F22452002073 DT. 30.07.2023 F22452002083 DT. 30.07.2023 F22452002082 DT. 30.07.2023 HBL NO BOM0057497 HBL NO BOM0057521 HLBU9470709 002 SCAC CODE YASV 37PALLETS 2553 CARTONS

DONATIONS TO THE GOVERNMENT HOSPITALS - HOSPITAL BEDS / STRETCHERS AND MEDICAL EQUIPMENT RELATED ITEMS FOR PATIENTS ADMITTED TO THE GOVERNMENT HOSPITALS IN SRI LANKA. THESE GOODS ARE GIVEN FREE OF CHARGE BY HOSPITAL SERVICES SUPPORT FOUNDATION CALIFORNIA

31 PALLETS 1800 CARTONS PHARMACEUTICALS AS UNDER PR AVASTATIN SOD TAB 40MG 500 ND C CODE:68462019705 FDA PRODUC T CODE NO.: 61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: MNBU0363400 001 -HYPOLIPDAEMIC URSODIOL T AB 250MG 100 NDC CODE:6846204 7301 FDA PRODUCT CODE NO.: 6 3 N C A 25 H. T. S NO.: 3004 .49.00.10 ANDA NO.: 90-801 T HERAPEUTICE USE: - FOR THE TR EATMENT OF PATIENTS WITH PRIM ARY BILIARY CIRRHOSIS" COL MNBU0363400 001 ESEVELAM HCL OS 3.75GM 30 NDC CODE:68462062030 FDA PRODUCT CODE NO.: 62 B C L 13 H. T. S NO.: 3004.49.00.10 ANDA N O.: 202190 THERAPEUTICE USE : - COLESEVELAM IS A LIPID (L OW DENSITY LIPOPROTIN CHOLEST EROL) REDUCING DRUG THAT IS U MNBU0363400 001 SEFUL FOR REDUCING CHOLESTERO L. GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PR ODUCT CODE NO: 61 N C A 69 H . T. S NO.: 3004.90.92.30 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT GABAPENTIN TAB 600MG 500 NDC MNBU0363400 001 CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-662 THERAPEUTICE USE:-A NTICONVULSANT AGENT TOPIRA MATE TAB 50MG 500 NDC CODE:68 462015305 FDA PRODUCT CODE NO .: 61 M C A 40 H. T. S NO.: MNBU0363400 001 3004.49.00.20 ANDA NO.:07762 7 THERAPEUTICE USE: ANTICONV ULSANT TOPIRAMATE TAB 50MG 1000 NDC CODE:68462015310 FD A PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.49.00.2 0 ANDA NO.:- 77-627 THERAPEU TICE USE:-ANTICONVULSANT G MNBU0363400 001 ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & MNBU0363400 001 CUSTOM INVOICE NO. F224520021 27 DT. 31.07.2023 F2245200210 2 DT. 31.07.2023 F22452002126 DT. 31.07.2023 F22452002107 DT. 31.07.2023 F22452002154 D T. 31.07.2023 S/BILL NO:29206 93 DT 02-AUG-2023 S/BILL NO:2 918719 DT 02-AUG-2023 S/BILL MNBU0363400 001 NO:2917733 DT 02-AUG-2023 S/B ILL NO:2917755 DT 02-AUG-2023 S/BILL NO:2917729 DT 02-AUG-2 023 NET WT:8026.085 NOTIFY P ARTY:2 GLENMARK PHARMACEUTICA LS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 U SA

16 PALLETS ELECTRONIC DEVICE FOR INSULIN CHECKING FOR PATIENTS WITH DIABETES. BRAND NAME: ACCU-CHEK SAFE-T-PRO PLUS NON-EU ACCU-CHEK SAFE-T-PRO UNO TCLU1351013 001 . WOODEN PACKING TREATED AND CERTIFIED . +++++ TEMPERATURE TO BE MAIN- TAINED AT PLUS 20 DEGREES CELSIUS THE WHOLE TCLU1351013 001 TRANSPORT +++++ MRN: 23DE323012274344E6 +++++ HS-CODE:90183900

9X A. WHEELCHAIRS 40X WALKERS 25X WHEELCHAIRS 21X WALKERS WITH SEAT 24X CANES 20X PAIRS OF CRUTCHES 3X BEDS FOR PATIENTS 22X HYGIENIC CHARIS (ON TOILET) 28X SHOWER CHAIRS 10X TOILET BOOSTER 56X ADULT DIAPER BOXES 11X CRANES TO LIFT PATIENTS 4X EQUIPMENT FOR MUSCULAR REHABILITATION 8X RIFTON WOODEN STANDARDS/ COLORS 3X BOXES WITH SPARE PARTS FOR WHEELCHAIRS 1X AIR MATTRESS WITH MOTOR 200X PAIR OF SHOES (VARIOUS SIZES) 150X BAGS OF WARM CLOTHING (10.000 UNITS) 4X BABY CRIBS 6X STROLLERS FOR BABIES 30X BLANKETS FOR BEDS TOTAL 675 PACKAGES FREIGHT PREPAID (Harmonized Code: 8713) OR SOFTWARE WERE EXPORTED FROM WITH THE EXPORT ADMINISTRATION TO U.S. LAW PROHIBITED.

25 PALLETS 1133 CARTONS PH ARMACEUTICALS AS UNDER DROS PIRENONE/EE TAB 3/0.02MG 84 N DC CODE:68462072029 FDA PRODU CT CODE NO.: 65 J D A 39 H. T. S NO.: 3006.60.00.00 ANDA NO.: 204296 THERAPEUTICE USE MNBU0207060 001 : - ORAL CONTRACEPTIVE MAR LISSA TAB 0.15/0.03MG 84 NDC CODE:68462038829 FDA PRODUCT CODE NO.: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO. : 091452 THERAPEUTICE USE: OR AL CONTRACEPTIVE CICLOPIRO X GEL 0.77% 45GM NDC CODE:684 MNBU0207060 001 62045547 FDA PRODUCT CODE NO. : 61WCJ43 H. T. S NO.: 3004 .49.00.50 ANDA NO.: 091595 T HERAPEUTICE USE: - ANTIFUNGAL CICLOPIROX GEL 0.77% 100GM NDC CODE:68462045594 FDA PR ODUCT CODE NO.: 61WCJ43 H. T . S NO.: 3004.49.00.50 ANDA MNBU0207060 001 NO.: 091595 THERAPEUTICE USE: - ANTIFUNGAL URSODIOL TAB 250MG 100 NDC CODE:684620473 01 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.4 9.00.10 ANDA NO.: 90-801 THE RAPEUTICE USE: - FOR THE TREA TMENT OF PATIENTS WITH PRIMAR MNBU0207060 001 Y BILIARY CIRRHOSIS" NAPRO XEN TAB 500MG 500 NDC CODE:68 462019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI-IN FLAMMATORY, ANALGESIC COMM ERCIAL & CUSTOM INVOICE NO. F MNBU0207060 001 22452001906 DT. 21.07.2023 F2 2452001908 DT. 21.07.2023 F22 452001914 DT. 21.07.2023 F224 52001915 DT. 21.07.2023 F2245 2001913 DT. 21.07.2023 F22452 001924 DT. 22.07.2023 S/BILL NO: 2660456 DT 23-JUL-2023 S/ BILL NO: 2660452 DT 23-JUL-202 MNBU0207060 001 3 S/BILL NO: 2660522 DT 23-JU L-2023 S/BILL NO: 2660521 DT 23-JUL-2023 S/BILL NO: 266052 3 DT 23-JUL-2023 S/BILL NO: 2 660520 DT 23-JUL-2023 NET WT. 3997.73 KGS 01 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA MNBU0207060 001 NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 SHOROUQ CO MMODITIES TRADING DMCC UNIT N O. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPL EX 2, DUBAI DUBAI UTD.ARAB EMIR.

MEDICAL DEVICES USED FOR THE IMMOBILIZATION OF CANCER PATIENTS DURING RADIATION TREATMENT.HS CODE 9022.9080FDA REGISTRATION OWNER OPERATOR 9015000

SLAC HAIR CARE FOR CANCER PATIENTS

PHARMACEUTICALS AS UNDER URSODIOL TAB 500M G 100 NDC CODE:68462047401 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 3004.49.00. 10 ANDA NO.: 90-801 THERAPEUTICE USE: - FOR THE TREATMENT OF PATIENTS WITH PRIMARY BI LIARY CIRRHOSIS" 01 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +18 DEGREES TEMP TTNU8772159 001 ERATURE RANGE : +15 DEGREES TO +25 DEGREES C OMMERCIAL & CUSTOM INVOICE NO. F22452000648 DT. 09.05.2023

27 PALLETS 1796 CARTONS P HARMACEUTICALS AS UNDER RAN OLAZINE ER TAB 500MG 60 NDC C ODE:68462031960 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT MNBU0516618 001 IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA RANOLAZIN MNBU0516618 001 E ER TAB 1000MG 60 NDC CODE:6 8462032060 FDA PRODUCT CODE N O.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.:2110 82 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATION. I T WORKS BY IMPROVING BLOOD FL OW TO HELP THE HEART WORK MOR MNBU0516618 001 E EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURI NG AN ACUTE (EMERGENCY) ATTAC K OF ANGINA EZETIMIBE-SIMV A TAB 10/40MG 30 NDC CODE:684 62032330 FDA PRODUCT CODE NO. : 61 J D C 15 H. T. S NO.: MNBU0516618 001 3004.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: - THIS C OMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTERO L AND FATS (SUCH AS LDL, TRI GLYCERIDES) AND RAISE GOOD CH OLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING MNBU0516618 001 THE AMOUNT OF CHOLESTEROL YO UR BODY ABSORBS FROM YOUR DIE T. SIMVASTATIN BELONGS TO A G ROUP OF DRUGS KNOWN AS "STATI NS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. TOPIRAMATE ER CAP (Q) 25MG 30 NDC CODE:684 MNBU0516618 001 62037230 3004.49.00.20 61 M C B 40 210278 RUFINAMIDE T AB 400MG 120 NDC CODE:6846207 1408 61 M C A 99 3004.90.92. 30 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR C ONTROL SEIZURES (EPILEPSY) A SSOCIATED WITH LENNOX-GASTAUT MNBU0516618 001 SYNDROME (LGS FENOFIBRATE CAP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 205566 T HERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, MNBU0516618 001 TOTAL-C, TRIGLYCERIDES AND A PO B IN DULT PATIENTS WITH P RMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVED ILOL TAB 12.5MG 500 NDC CODE: 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 MNBU0516618 001 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST EZETIMIBE-SIMVA TAB 10/40MG 90 NDC CODE:68462032390 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTIC E USE: :#LIPID LOWERING AGENT MNBU0516618 001 TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M MNBU0516618 001 ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22487000139 DT. 26.04.2023 F MNBU0516618 001 22487000141 DT. 26.04.2023 F2 2487000142 DT. 26.04.2023 S /BILL NO:4005995 DT:27.04.2023 S/BILL NO:4005998 DT:27.04.2 023 S/BILL NO:4006001 DT:27.0 4.2023 NET WT.:2452.388 NO TIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC MNBU0516618 001 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

MEDICAL EQUIPMENT: PATIENTS BED PATIENTS STRETCHERS BABIES BASSINET PATIENTS VITALS SIGNS MONITOR CRASH CART SCAN MACHINE RECLINER CHAIRS

1 LOT OF MEDICAL EQUIPMENT: PATIENTS BED PATIENTS STRETCHERS BABIES BASSINET PATIENTS VITALS SIGNS MONITOR CRASH CART SCAN MACHINE RECLINER CHAIRS

42 PALLETS 2158 CARTONS PH ARMACEUTICALS AS UNDER CLIN DAMYCIN HCL CAP 75MG 100 NDC CODE:68462014201 CLINDAMYCI N HCL CAP 300MG 100 NDC CODE: 68462014401 TOPIRAMATE ER C AP (Q) 100MG 30 NDC CODE:6846 MNBU0292082 001 2037430 3004.49.00.20 61 M C B 40 210278 FENOFIBRATE C AP 67MG 100 NDC CODE:68462058 001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90 .92.20 ANDA NO.: 205566 THER APEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FO MNBU0292082 001 R THE REDUCTION OF LDL-C, TO TAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMA RY HYPERCHOLESTEROLEMIA OR M IXED DYSLIPIDEMIA CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 MNBU0292082 001 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST CHL ORPROMAZINE HCL TAB 10MG 100 NDC CODE:68462086101 61 T C A 04 3004.90.92.40 212144 TO TREAT PSYCHOTIC DISORDERS SU CH AS SCHIZOPHRENIA OR MANIC MNBU0292082 001 -DEPRESSION IN ADULTS POTA SSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA N O.: 202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMIA TACROLIMUS CAP MNBU0292082 001 0.5MG 100 NDC CODE:684620685 01 FDA PRODUCT CODE NO.: 64 T C E 08 H. T. S NO.:3004.90 .92.15 ANDA NO.: 206662 THER APEUTICE USE: :#TO PREVENT RE JECTION OF A KIDNEY,TO PREVEN T REJECTION OF A KIDNEY,LIVER TRANSPLANT CLINDAMYCIN HC MNBU0292082 001 L CAP 150MG 100 NDC CODE:6846 2014301 TACROLIMUS OINT 0.1 % 60GM NDC CODE:68462053465 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00 .50 ANDA NO.: 210393 THERAPE UTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OI MNBU0292082 001 NTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPI C DERMATITIS (ECZEMA). COM MERCIAL & CUSTOM INVOICE NO. F22487000039 DT. 10.04.2023 F 22487000040 DT. 10.04.2023 F2 2487000041 DT. 10.04.2023 F22 487000042 DT. 10.04.2023 F224 MNBU0292082 001 87000043 DT. 10.04.2023 F2248 7000044 DT. 10.04.2023 S/BILL NO: 4005171 DT: 11.04.2023 S/BILL NO: 4005175 DT: 11.04. 2023 S/BILL NO: 4005172 DT: 11.04.2023 S/BILL NO: 4005176 DT: 11.04.2023 S/BILL NO: 4 005175 DT: 11.04.2023 S/BILL MNBU0292082 001 NO: 4005174 DT: 11.04.2023 NET WT.4254.095 02 DATA LOG GERS HUMIDITY:65% SET TEMPER ATURE : +20 DEGREES TEMPERATU RE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENM ARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MNBU0292082 001 MAHWAH - 07430 USA

35 PALLETS 2250 CARTONS PHARMACEUTICALS AS UNDER G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-662 THERAPEUTICE USE:-A MNBU0295651 001 NTICONVULSANT AGENT RANOLA ZINE ER TAB 1000MG 60 NDC COD E:68462032060 FDA PRODUCT COD E NO.: 61 D C B 02 H. T. S N O.: 3004.49.00.10 ANDA NO.:2 11082 THERAPEUTIC USE: - IT I S AN ANTI-ANGINAL MEDICATION . IT WORKS BY IMPROVING BLOOD MNBU0295651 001 FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHE ST PAIN). IT IS NOT FOR USE D URING AN ACUTE (EMERGENCY) AT TACK OF ANGINA TOPIRAMATE ER CAP (Q) 25MG 30 NDC CODE:6 8462037230 3004.49.00.20 61 MNBU0295651 001 M C B 40 210278 INDOMETHAC IN ER CAP 75MG 60 NDC CODE:68 462032560 FDA PRODUCT CODE: 6 2 GCE42 H. T. S NO.:3004.90 .92.40 ANDA NO.203501 THERAP EUTIC USE: INDOMETHACIN IS US ED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED MNBU0295651 001 BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITIS. IT IS ALSO U SED TO RELIEVE PAIN FROM VARI OUS OTHER CONDITIONS. THIS M EDICATION IS KNOWN AS A NONST EROIDAL ANTI-INFLAMMATORY DRU G (NSAID). ... THIS EFFECT H ELPS TO DECREASE SWELLING AND MNBU0295651 001 PAIN. FENOFIBRATE CAP 134 MG 100 NDC CODE:68462058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUN CTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C MNBU0295651 001 , TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY H YPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA TACROLIMUS OIN T 0.1% 30GM NDC CODE:68462053 435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004. 49.00.50 ANDA NO.: 210393 TH MNBU0295651 001 ERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIV E OINTMENT USED FOR THE TREA TMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). TACROLIMUS OINT 0.1% 60GM N DC CODE:68462053465 FDA PRODU CT CODE NO.: 64 T C J 08 H. MNBU0295651 001 T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT US ED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATI TIS (ECZEMA). TACROLIMUS C AP 1MG 100 NDC CODE:684620686 MNBU0295651 001 01 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.2 06662 THERAPEUTIC USE : TO P REVENT REJECTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT INDOMETHACIN ER CAP 75MG 90 NDC CODE:68462032590 FDA PROD UCT CODE NO.: 62 GCE42 H. T. MNBU0295651 001 S NO.: 3004.90.92.40 ANDA N O.: 203501 THERAPEUTICE USE: #INDOMETHACIN IS USED TO REL IEVE PAIN, SWELLING AND JOINT STIFFNESS CAUSED BY ARTHRITI S, GOUT, BURSITIS AND TENDONI TIS IT IS ALSO USED TO RELIEV E PAIN FROM VARIOUS OTHER CO MNBU0295651 001 NDITIONS.THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI -INFLAMMATORY DRUG THIS EFFEC T HELPS TO DECREASE SWELLING AND PAIN. COMMERCIAL & CUS TOM INVOICE NO. F22387002162 DT. 22.02.2023 F22387002164 D T. 22.02.2023 F22387002169 DT MNBU0295651 001 . 23.02.2023 F22387002166 DT. 22.02.2023 F22387002165 DT. 22.02.2023 NET WT. 3678.343 KGS 02 DATA LOGGERS HUMIDIT Y:65% SET TEMPERATURE : +20 D EGREES TEMPERATURE RANGE : +1 5 DEGREES TO +25 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU MNBU0295651 001 TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 0 USA S/BILL NO: 4002607 D T: 23.02.2023 S/BILL NO: 4002 604 DT: 23.02.2023 S/BILL NO: 4002608 DT: 23.02.2023 S/BIL L NO: 4002603 DT: 23.02.2023 S/BILL NO: 4002605 DT: 23.02.2 MNBU0295651 001 023

SLAC MAILING MACHINERY, PUMP COMPONENTS, GARM ENTS, HAIRCARE FOR CANCER PATIENTS, LIFTING E QUIPMENT, CAR CARE PRODUCTS, PALLET RACKS

37 PALLETS 3044 CARTONS PHARMACEUTICALS AS UNDER EZ ETIMIBE TAB 10MG 500 NDC CODE :68462022605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO .: 3004.49.00.10 ANDA NO.: # 078560 THERAPEUTICE USE: LIPI MNBU0633070 001 D LOWERING AGENT EZETIMIBE TAB 10MG 90 NDC CODE:6846202 2690 FDA PRODUCT CODE NO.: 6 1 J C A 15 H. T. S NO.: 3004 .49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOWER ING AGENT PROPAFENONE HCL E R CAP 225MG 60 NDC CODE:68462 MNBU0633070 001 040860 FDA PRODUCT CODE NO.: 63 E C F 28 H. T. S NO.: 30 04.49.00.10 ANDA NO.:205268 THERAPEUTICE USE:AN ANTIARRHY THMIC AGENT. IT IS USED TO TR EAT IRREGULAR HEART RHYTHM A ND CAN SLOW RAPID HEARTBEATS INDOMETHACIN ER CAP 75MG 9 MNBU0633070 001 0 NDC CODE:68462032590 FDA P RODUCT CODE NO.: 62 GCE42 H. T. S NO.: 3004.90.92.40 AND A NO.: 203501 THERAPEUTICE US E: #INDOMETHACIN IS USED TO RELIEVE PAIN, SWELLING AND JO INT STIFFNESS CAUSED BY ARTHR ITIS, GOUT, BURSITIS AND TEND MNBU0633070 001 ONITIS IT IS ALSO USED TO REL IEVE PAIN FROM VARIOUS OTHER CONDITIONS.THIS MEDICATION IS KNOWN AS A NONSTEROIDAL A NTI-INFLAMMATORY DRUG THIS EF FECT HELPS TO DECREASE SWELLI NG AND PAIN. FENOFIBRATE C AP 134MG 100 NDC CODE:6846205 MNBU0633070 001 8101 FDA PRODUCT CODE NO.: 6 1 JCE 09 H. T. S NO.: 3004.9 0.92.20 ANDA NO.: 205566 THE RAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET F OR THE REDUCTION OF LDL-C, T OTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRM MNBU0633070 001 ARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA COLESEVE LAM HCL TAB 625MG 180 NDC COD E:68462043318 FDA PRODUCT COD E NO.: 62 B D A 13 H. T. S N O.: 3004.49.00.10 ANDA NO.: 203480 THERAPEUTICE USE: - A NTIHYPERLIPO PROTEINEMIC. MNBU0633070 001 POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRO DUCT CODE NO.: 65 R C F 14 H . T. S NO.: 3004.90.92.90 AN DA NO.: 202868 THERAPEUTICE U SE: - TREATMENT OR PREVENTION OF HYPOKALEMIA TACROLIMUS CAP 1MG 100 NDC CODE:6846206 MNBU0633070 001 8601 HTS NO: 3004.90.92.15 F DA CODE : 64 T C E 08 ANDA NO .206662 THERAPEUTIC USE : TO PREVENT REJECTION OF A KIDNE Y,HEART, OR LIVER TRANSPLANT TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PROD UCT CODE NO.: 64 T C J 08 H. MNBU0633070 001 T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). COMMERCIAL & CUSTOM INVOICE NO. F2238700 MNBU0633070 001 2008 DT. 30.01.2023 F22387002 010 DT. 31.01.2023 F223870020 12 DT. 31.01.2023 S/BILL NO: 4001310 DT: 31.01.2023 S/BIL L NO:4001320 DT: 31.01.2023 S/BILL NO:4001330 DT: 31.01.2 023 NET WT. 3912.588 KGS 02 DATA LOGGERS HUMIDITY:65% SE MNBU0633070 001 T TEMPERATURE : +20 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

FREIGHT PREPAID THIS MASTER BILL COVERS NON-AUTOMATED NVOCC HOUSE BILL NUMBER : FR40302323 PADDLE HOLDERS BITE BLOCK EDENTULOUS PATIENTS QA TEST PATTERN FOR 3D HS CODE : APHU6559815 001 HTS-6 :902212-902290 HTS-6 :481910-441510 HTS-6 :441510-902780 HTS-6 :901849

37 PALLETS 2426 CARTONS PHARMACEUTICALS AS UNDER GA BAPENTIN TAB 600MG 500 NDC CO DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT MNBU9111190 001 ICONVULSANT AGENT TACROLIM US OINT 0.1% 30GM NDC CODE:68 462053435 FDA PRODUCT CODE NO .: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 2103 93 THERAPEUTICE USE: - TACRO LIMUS IS A TOPICAL IMMUNOSUPP RESSIVE OINTMENT USED FOR THE MNBU9111190 001 TREATMENT OF MODERATE-TO-SE VERE ATOPIC DERMATITIS (ECZE MA). PRAVASTATIN SOD TAB 10 MG 500 NDC CODE:68462019505 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.:-77-987 THERAPE UTICE USE:-HYPOLIPDAEMIC P MNBU9111190 001 RAVASTATIN SOD TAB 20MG 500 N DC CODE:68462019605 FDA PRODU CT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE US E:-HYPOLIPDAEMIC PROPAFENON E HCL ER CAP 425MG 60 NDC COD E:68462041060 FDA CODES 63 E MNBU9111190 001 C F 28 HTS CODES 3004.49.00. 10 ANDA NO. 205268 THERAPEUT IC USE AN ANTIARRHYTHMIC AGEN T.IT IS USED TO TREAT IRREGUL AR HEART RHYTHM AND CAN SLOW RAPID HEARTBEATS. POTASSIU M CL ER CAP 10MEQ 500 NDC COD E:68462035705 FDA PRODUCT COD MNBU9111190 001 E NO.: 65 R C F 14 H. T. S N O.: 3004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - T REATMENT OR PREVENTION OF HYP OKALEMIA FENOFIBRATE CAP 67 MG 100 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.2 MNBU9111190 001 0 ANDA NO.: 205566 THERAPEUT ICE USE: - INDICATED AS ADJUN CTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C , TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY H YPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA GABAPENTIN TAB MNBU9111190 001 600MG 500 NDC CODE:684620126 05 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90 .92.30 ANDA NO.:-77-662 THER APEUTICE USE:-ANTICONVULSANT AGENT BISOPROLOL-HCTZ TAB 10/6.25MG 100 NDC CODE:684620 88001 FDA PRODUCT CODE NO.: MNBU9111190 001 62 O D A 18 H. T. S NO.: 300 4.40.00.20 ANDA NO.: 215995 THERAPEUTICE USE: BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENS ION. FENOFIBRATE CAP 67MG 1 00 NDC CODE:68462058001 FDA MNBU9111190 001 PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 A NDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIV E THERAPY TO DIET FOR THE RE DUCTION OF LDL-C, TOTAL-C, TR IGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPER MNBU9111190 001 CHOLESTEROLEMIA OR MIXED DYSL IPIDEMIA GABAPENTIN TAB 600 MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92. 30 ANDA NO.:-77-662 THERAPEU TICE USE:-ANTICONVULSANT AGE NT COMMERCIAL & CUSTOM INVO MNBU9111190 001 ICE NO. F22387001880 DT. 10.0 1.2023 F22387001879 DT. 10.01 .2023 F22387001877 DT. 10.01. 2023 F22387001875 DT. 10.01.2 023 F22387001882 DT. 11.01.20 23 F22387001885 DT. 11.01.202 3 NET WT.6729.197 KGS 02 DAT A LOGGERS NOTIFY PARTY:2 G MNBU9111190 001 LENMARK PHARMACEUTICALS INC 7 50, CORPORATE DRIVE, NEW JERS EY MAHWAH - 07430 USA S/B ILL NO: 4000334 DT: 11.01.2023 S/BILL NO: 4000338 DT: 11.01 .2023 S/BILL NO: 4000335 DT: 11.01.2023 S/BILL NO: 4000336 DT: 11.01.2023 S/BILL NO: 40 MNBU9111190 001 00345 DT: 11.01.2023 S/BILL N O: 4000360 DT: 11.01.2023

10 PALLETS 778 CARTONS PHA RMACEUTICALS AS UNDER NAPRO XEN TAB 500MG 500 NDC CODE:68 462019005 FDA PRODUCT CODE N O.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-2 50 THERAPEUTICE USE:-ANTI-IN MNBU9167733 001 FLAMMATORY, ANALGESIC URSO DIOL TAB 250MG 100 NDC CODE:6 8462047301 FDA PRODUCT CODE N O.: 63 N C A 25 H. T. S NO.: 3004.49.00.10 ANDA NO.: 90- 801 "THERAPEUTICE USE: - FOR THE TREATMENT OF PATIENTS WI TH PRIMARY BILIARY CIRRHOSIS" MNBU9167733 001 THE TREATMENT OF PATIENTS W ITH PRIMARY BILIARY CIRRHOSIS " TOPIRAMATE TAB 50MG 500 NDC CODE:68462015305 FDA PROD UCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 AND A NO.:077627 THERAPEUTICE USE : ANTICONVULSANT COMMERCIA MNBU9167733 001 L & CUSTOM INVOICE NO. F22352 004391 DT. 23.12.2022 F223520 04392 DT. 23.12.2022 F2235200 4393 DT. 23.12.2022 S/BILL NO : 6420036 DT 24-DEC-2022 S/BI LL NO: 6420037 DT 24-DEC-2022 S/BILL NO: 6420015 DT 24-DEC- 2022 NET WT.2097.080 KGS 01 MNBU9167733 001 DATA LOGGERS SET TEMPERATUR E : +18 DEGREES NOTIFY PART Y:2 SHOROUQ COMMODITIES TRADI NG DMCC UNIT NO. 98, DMCC BUS INESS CENTRE, LEVEL NO. 8, JE WELLERY & GEMPLEX 2, DUBAI D UBAI UTD.ARAB EMIR.

45 PALLETS 2997 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 800MG 500 NDC CODE :68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-662 THERAPEUTICE USE:-ANTI MNBU0142760 001 CONVULSANT AGENT URSODIOL TAB 500MG 100 NDC CODE:684620 47401 FDA PRODUCT CODE NO.: 63 N C A 25 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 90-801 "THERAPEUTICE USE: - FOR THE TREATMENT OF PATIENTS WITH PR IMARY" BILIARY CIRRHOSIS" MNBU0142760 001 FLUCONAZOLE TAB 50MG 30 NDC C ODE:68462010130 FDA PRODUCT C ODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 ANDA NO. :-77 - 253 THERAPEUTICE USE: -ANTIFUNGAL ROPINIROLE TAB 2MG 100 NDC CODE:68462025601 FDA PRODUCT CODE NO.:-62 J C MNBU0142760 001 A 17 H. T. S NO.: 3004.90.9 2.40 ANDA NO.:- 90-135 THERA PEUTICE USE:-TREATMENT OF PA RKINSONISM RIZATRIPTAN BENZ TAB 10MG 18UD NDC CODE:68462 046699 FDA PRODUCT CODE NO.: 60 L C A 87 H. T. S NO.: 30 04.90.92.28 ANDA NO.:201967 MNBU0142760 001 THERAPEUTICE USE: - ACUTE TRE ATMENT OF MIGRAINE MUPIROC IN CREAM 2% 30GM NDC CODE:684 62056435 FDA PRODUCT CODE NO. : 61GCJ82 H. T. S NO.: 3004 .90.92.45 ANDA NO.: 201587 T HERAPEUTICE USE: - TOPICAL AN TI-BACTERIAL COMMERCIAL & C MNBU0142760 001 USTOM INVOICE NO. F2235200394 4 DT. 27.11.2022 F22352003945 DT. 27.11.2022 F22352003947 DT. 27.11.2022 S/BILL NO: 577 6530 DT:28-NOV-22 S/BILL NO: 5777599 DT:28-NOV-22 S/BILL N O: 5776461 DT:28-NOV-22 NET W T:9464.34 KGS 02 DATA LOGGER MNBU0142760 001 S SET TEMPERATURE : +18 D EGREES CONTAINER NO. MNBU0 142760 NOTIFY PARTY:2 GL ENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

PUZZLES FOR ALZHEIMER PATIENTS

38 PALLETS 2679 CART ONS PHARMACEUTICALS AS UNDE R SIROLIMUS TAB 2MG 100 ND C CODE:68462068401 FDA PRODUC T CODE NO.: 64 T C A 12 H. T . S NO.: 3004.90.92.15 ANDA NO.: 208691 THERAPEUTICE USE: MNBU4187207 001 TO PREVENT REJECTION OF KID NEY TRANSPLANTS. GABAPENTIN TAB 600MG 500 NDC CODE:68462 012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 300 4.90.92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULS ANT AGENT PRAVASTATIN SOD MNBU4187207 001 TAB 40MG 90 NDC CODE:68462019 790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004. 90.92.20 ANDA NO.: 77-987 TH ERAPEUTICE USE: -HYPOLIPDAEMI C POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FD A PRODUCT CODE NO.:65 R C F 1 MNBU4187207 001 4 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTIC E USE: - TREATMENT OR PREVENT ION OF HYPOKALEMIA FENOFI BRATE CAP 134MG 100 NDC CODE: 68462058101 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 2055 MNBU4187207 001 66 THERAPEUTICE USE: - INDIC ATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LD L-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS W ITH PRMARY HYPERCHOLESTEROLEM IA OR MIXED DYSLIPIDEMIA A MLOD-OLMESARTAN TAB 5/20MG 30 MNBU4187207 001 NDC CODE:68462056630 FDA PRO DUCT CODE NO.: 62 C D A 68 H . T. S NO.: 3004.90.92.20 AN DA NO.: 207807 THERAPEUTICE U SE: -MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND COR ONARY ARTERY DISEASE PRAVAS TATIN SOD TAB 40MG 500 NDC CO MNBU4187207 001 DE:68462019705 FDA PRODUCT CO DE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: -H YPOLIPDAEMIC OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039 730 FDA PRODUCT CODE NO.: 62 KCF10 H. T. S NO.: 3004.90.9 MNBU4187207 001 160 ANDA NO.: 91672 THERAPEU TICE USE: - -TREATMENT OF TRE AT GASTROESOPHAGEAL REFLUX D ISEASE COMMERCIAL & CUSTOM INVOICE NO. F22387001130 DT. 30.09.2022 F22387001233 DT. 1 5.10.2022 F22387001237 DT. 15 .10.2022 F22387001238 DT. 15. MNBU4187207 001 10.2022 NET WT. 7,294.54 0 2 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A S/BILL NO: 4014874 DT: 17 .10.2022 S/BILL NO: 4014875 D MNBU4187207 001 T: 17.10.2022 S/BILL NO: 4014 876 DT: 17.10.2022 S/BILL NO: 4014878 DT: 17.10.2022

21 PALLETS 612 CARTONS PHA RMACEUTICALS AS UNDER CLOBE TASOL PROP SOLN 0.05% 50ML ND C CODE:68462053253 FDA PRODUC T CODE NO.: 64 L C L 67 H. T . S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE: MNBU3469994 001 - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONSTE RILE LIQUID / CLOBETASOL PROP IONATE (GLUCOCORTICOID) MO METASONE FURO CREAM 0.1% 45GM NDC CODE:68462019255 FDA PRO DUCT CODE NO.: 62 F C J 53 H . T. S NO.: 3004.40.49.50 AN MNBU3469994 001 DA NO.:78-541 THERAPEUTICE US E: ANTI-INFLAMMATORY- DERMAT OLOGIC MOMETASONE FURO SOLN 0.1% 60ML NDC CODE:684620385 02 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 3004.9 0.92.45 ANDA NO.:090506 THER APEUTICE USE: MOMETASONE FURO MNBU3469994 001 ATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICAT ED FOR THE RELIEF OF THE INF LAMMATORY AND PRURITIC MANIFE STATIONS OF CORTICOSTEROID-RE SPONSIVE DERMATOSES IN PATIEN TS #12 YEARS OF AGE. MOME TASONE FURO SOLN 0.1% 60ML ND MNBU3469994 001 C CODE:68462038502 FDA PRODUC T CODE NO.: 62 F C L 53 H. T . S NO.: 3004.90.92.45 ANDA NO.:090506 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL S OLUTION (LOTION) IS A CORT ICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATORY AN MNBU3469994 001 D PRURITIC MANIFESTATIONS OF CORTICOSTEROID-RESPONSIVE DE RMATOSES IN PATIENTS #12 YEA RS OF AGE. MOMETASONE FURO SOLN 0.1% 60ML NDC CODE:68462 038502 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO.: 30 04.90.92.45 ANDA NO.:090506 MNBU3469994 001 THERAPEUTICE USE: MOMETASONE FUROATE TOPICAL SOLUTION (LOT ION) IS A CORTICOSTEROID IND ICATED FOR THE RELIEF OF THE INFLAMMATORY AND PRURITIC MA NIFESTATIONS OF CORTICOSTEROI D-RESPONSIVE DERMATOSES IN PA TIENTS #12 YEARS OF AGE. MNBU3469994 001 COMMERCIAL & CUSTOM INVOICE NO . F22335003142 DT. 12.10.2022 F22335003168 DT. 13.10.2022 F22335003207 DT. 15.10.2022 S/BILL NO: 4778492 DT: 12/10/ 2022 S/BILL NO: 4803493 DT:1 3/10/2022 S/BILL NO: 4867760 DT:17/10/2022 NET WT. 2,228. MNBU3469994 001 64 KGS 21 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +1 8 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 7430 USA

PUZZLES FOR ALZHEIMER PATIENTS

26 PALLETS 662 CARTONS PH ARMACEUTICALS AS UNDER CLOB ETASOL PROP SOLN 0.05% 25ML N DC CODE:68462053228 FDA PRODU CT CODE NO.: 64 L C L 67 H. T. S NO.: 3004.90.92.45 ANDA NO.: 210190 THERAPEUTICE USE MNBU3471435 001 : - GLUCOCORTICOID / HUMAN - RX/SINGLE INGREDIENT / NONST ERILE LIQUID / CLOBETASOL PRO PIONATE (GLUCOCORTICOID) T RIAMCINOLONE ACE OINT 0.5% 15G M NDC CODE:68462079817 FDA P RODUCT CODE NO.:64 L C J 61 H. T. S NO.: 3004.49.00.50 A MNBU3471435 001 NDA NO.:206379 THERAPEUTICE U SE: - REDUCES THE SWELLING, ITCHING, AND REDNESS OF SKIN MOMETASONE FURO SOLN 0.1% 6 0ML NDC CODE:68462038502 FDA PRODUCT CODE NO.: 62 F C L 5 3 H. T. S NO.: 3004.90.92.45 ANDA NO.:090506 THERAPEUTIC MNBU3471435 001 E USE: MOMETASONE FUROATE TO PICAL SOLUTION (LOTION) IS A CORTICOSTEROID INDICATED FOR THE RELIEF OF THE INFLAMMATO RY AND PRURITIC MANIFESTATION S OF CORTICOSTEROID-RESPONSIV E DERMATOSES IN PATIENTS #12 YEARS OF AGE. MOMETASONE MNBU3471435 001 FURO SOLN 0.1% 30ML NDC CODE: 68462038537 FDA PRODUCT CODE NO.: 62 F C L 53 H. T. S NO. : 3004.90.92.45 ANDA NO.:090 506 THERAPEUTICE USE: MOMETA SONE FUROATE TOPICAL SOLUTION (LOTION) IS A CORTICOSTEROI D INDICATED FOR THE RELIEF OF MNBU3471435 001 THE INFLAMMATORY AND PRURITI C MANIFESTATIONS OF CORTICOS TEROID-RESPONSIVE DERMATOSES IN PATIENTS #12 YEARS OF AGE . MOMETASONE FURO OINT 0.1% 45GM NDC CODE:68462022555 F DA PRODUCT CODE NO.: 62 F C J 53 H. T. S NO.: 3004.40.49. MNBU3471435 001 50 ANDA NO.:78-571 THERAPEUT ICE USE: ANTI-INFLAMMATORY- DERMATOLOGIC COMMERCIAL & C USTOM INVOICE NO. F2233500286 5 DT. 28.09.2022 F22335002878 DT. 29.09.2022 S/BILL NO: 4 520878 DT:29/09/2022 S/BILL N O: 4547428 DT:30/09/2022 NET MNBU3471435 001 WT.2287.68 26 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RA NGE : +15 DEGREES TO +25 DEGRE ES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA

6 PALLETS 367 CARTON S PHARMACEUTICALS AS UNDER GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-662 THERAPEUTICE USE:- MNBU3505094 001 ANTICONVULSANT AGENT FENOF IBRATE CAP 67MG 100 NDC CODE: 68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 ANDA NO.: 2055 66 THERAPEUTICE USE: - INDIC ATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LD MNBU3505094 001 L-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS W ITH PRMARY HYPERCHOLESTEROLEM IA OR MIXED DYSLIPIDEMIA A MLOD-OLMESARTAN TAB 10/40MG 30 NDC CODE:68462056930 FDA PR ODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.20 A MNBU3505094 001 NDA NO.: 207807 THERAPEUTICE USE: MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND COR ONARY ARTERY DISEASE COMMER CIAL & CUSTOM INVOICE NO. F22 387001101 DT. 30.09.2022 F223 87001122 DT. 30.09.2022 F2238 7001140 DT. 30.09.2022 S/BILL MNBU3505094 001 NO: 4014364 DT:06/10/2022 S/BILL NO: 4014367 DT:06/10/2 022 S/BILL NO: 4014372 DT:06 /10/2022 NET WT. 882.37 3 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW MNBU3505094 001 JERSEY MAHWAH - 07430 USA